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a b s t r a c t
Planar cell polarity (PCP) signaling is an evolutionarily conserved mechanism that coordinates polarized
cell behavior to regulate tissue morphogenesis during vertebrate gastrulation, neurulation and
organogenesis. In Xenopus and zebraﬁsh, PCP signaling is activated by non-canonical Wnts such as
Wnt11, and detailed understanding of Wnt11 expression has provided important clues on when, where
and how PCP may be activated to regulate tissue morphogenesis. To explore the role of Wnt11 in
mammalian development, we established a Wnt11 expression and lineage map with high spatial and
temporal resolution by creating and analyzing a tamoxifen-inducible Wnt11‐CreER BAC (bacterial
artiﬁcial chromosome) transgenic mouse line. Our short- and long-term lineage tracing experiments
indicated that Wnt11‐CreER could faithfully recapitulate endogenous Wnt11 expression, and revealed for
the ﬁrst time that cells transiently expressing Wnt11 at early gastrulation were fated to become
speciﬁcally the progenitors of the entire endoderm. During mid-gastrulation, Wnt11‐CreER expressing
cells also contribute extensively to the endothelium in both embryonic and extraembryonic compart-
ments, and the endocardium in all chambers of the developing heart. In contrast, Wnt11‐CreER
expression in the myocardium starts from late-gastrulation, and occurs in three transient, sequential
waves: ﬁrst in the precursors of the left ventricular (LV) myocardium from E7.0 to 8.0; subsequently in
the right ventricular (RV) myocardium from E8.0 to 9.0; and ﬁnally in the superior wall of the outﬂow
tract (OFT) myocardium from E8.5 to 10.5. These results provide formal genetic proof that the majority of
the endocardium and myocardium diverge by mid-gastrulation in the mouse, and suggest a tight spatial
and temporal control of Wnt11 expression in the myocardial lineage to coordinate with myocardial
differentiation in the ﬁrst and second heart ﬁeld progenitors to form the LV, RV and OFT. The insights
gained from this study will also guide future investigations to decipher the role of non-canonical Wnt/
PCP signaling in endoderm development, vasculogenesis and heart formation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
In mice and humans there are 19 independent Wnt genes,
encoding secreted glycoproteins that have diverse and critical
roles during embryonic development, in adult tissue homeostasis
and in human diseases (Willert and Nusse, 2012). Wnt ligands can
be broadly divided into two classes: canonical Wnts such as Wnt1
and Wnt3a, and non-canonical Wnts such as Wnt5a and Wnt11.
Canonical Wnts bind to Frizzled (Fz) receptors and the Lrp5/6
family of co-receptors to activate cytoplasmic protein Disheveled
(Dsh/Dvl), which in turn stabilizes β-catenin to activate gene
transcription. Non-canonical Wnts, on the other hand, share
certain components with the canonical Wnt pathway such as Fz
and Dsh/Dvl, but signal through multiple β-catenin independent
branches that include the Wnt/Ca2þ and the planar cell polarity
(PCP) pathways (Angers and Moon, 2009; MacDonald et al., 2009;
van Amerongen and Nusse, 2009; Wallingford et al., 2000).
Of these non-canonical Wnt signaling branches, the PCP path-
way has been studied most extensively in various vertebrate and
invertebrate model organisms. Initially identiﬁed as one of the
signaling mechanisms that coordinate cellular polarity in the
plane of the epithelium, PCP signaling also regulates polarized
cell behavior such as mediolateral (M-L) cell intercalation and
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directional migration during convergent extension (CE) tissue
morphogenesis (Keller, 2002; Zallen, 2007). In addition to Fz and
Dsh/Dvl, the PCP pathway requires a set of distinct “core” proteins
such as the tetraspan membrane protein Van Gogh (Vang/Vangl)
and the atypical cadherin Flamingo (Fmi). What functions down-
stream of these core proteins as PCP effectors remains elusive and
is likely to be context- and tissue-dependent, and may include JNK,
small GTPase Rho/Rac/Cdc42 and the formin protein Daam1
(Goodrich and Strutt, 2011; Habas et al., 2001; Tree et al., 2002;
Wallingford, 2012).
In Xenopus and zebraﬁsh, Wnt5a and Wnt11 have been identi-
ﬁed as two primary ligands capable of activating non-canonical
Wnt/PCP signaling to regulate tissue morphogenesis during gas-
trulation (Heisenberg et al., 2000; Kilian et al., 2003; Tada and
Smith, 2000; Walentek et al., 2013; Wallingford et al., 2001),
although in other contexts, they can also activate canonical Wnt
signaling (Cha et al., 2008, 2009; Tao et al., 2005). During
gastrulation, Wnt11 acts in both cell-autonomous and cell-non-
autonomous fashion to regulate polarized cell intercalation and
directional migration of mesodermal and endodermal cells
(Heisenberg et al., 2000; Ulrich et al., 2003; Witzel et al., 2006).
Consequently, perturbing Wnt11 expression results in failure of
axial elongation and midline convergence of foregut endoderm in
frog and zebraﬁsh embryos (Heisenberg et al., 2000; Li et al., 2008;
Matsui et al., 2005; Tada and Smith, 2000; Walentek et al., 2013).
In the mouse, PCP signaling has so far been implicated in a
number of processes such as neurulation and cardiovascular and
limb development (van Amerongen, 2012; Wang et al., 2012). PCP-
mediated tissue morphogenesis is likely to have an even broader
impact on mammalian development and human diseases. Given
the essential roles of Wnt5a/Wnt11 in initiating PCP signaling and
the fact that they act in paracrine or autocrine fashion, determin-
ing their spatial and temporal expression pattern will shed light on
where and when PCP signaling is potentially activated, and
provide hints on what additional processes and tissues may
require PCP function. Indeed, in situ hybridization studies ofWnt5a
expression have led to novel models as to how PCP signaling could
be operative in mammals to regulate heart and limb development
(Gao et al., 2011; Gros et al., 2010; Sinha et al., 2012; Yamaguchi
et al., 1999a).
In comparison, our understanding of Wnt11 in the mouse is
more limited. In situ studies indicate that Wnt11 is expressed ﬁrst
in a scattered pattern around the primitive streak at early
gastrulation, and later on in the developing heart, posterior trunk
and urogenital system (Kispert et al., 1996). Wnt11 / mouse
embryos display no major gastrulation defects, but die in-utero or
shortly after birth with multiple cardiac defects (Majumdar et al.,
2003; Nagy et al., 2010; Zhou et al., 2007). Due to limited spatial
and temporal resolution, the existing RNA in situ data do not
provide sufﬁcient information as to which cardiac lineage
(s) express Wnt11 and the duration of Wnt11 expression in that
lineage, and therefore the spatio-temporal requirement for Wnt11
in heart development remains to be elucidated. Moreover, in situ
based expression studies often cannot inform us of the potential
fate and lineage of the cells expressing the gene of interest, for
instance the scattered Wnt11-expressing cells during early gas-
trulation in the mouse (Kispert et al., 1996).
To overcome the limitations of in situ hybridization, and to
establish a Wnt11 expression map with high spatial and temporal
resolution and lineage information, we generated a tamoxifen
inducible Wnt11-CreER transgene using BAC (Bacterial Artiﬁcial
Chromosome) recombineering technology. Because of their large
size (150–300 kb), BAC transgenes have been shown to recapitulate
endogenous gene expression patterns (Lee et al., 2001). CreER-T2
encodes a fusion protein between Cre and a mutated estrogen
receptor (ER) (Feil et al., 1997; Leone et al., 2003). CreER is normally
sequestered in the cytoplasm by the ER domain. Exposure to
tamoxifen leads to a temporary relief in this sequestration, allowing
CreER to enter the nucleus and induce recombination. By crossing
Wnt11-CreER with Rosa26 Cre reporters (R26R) (Madisen et al.,
2010; Soriano, 1999) and administering tamoxifen during gestation,
we can transiently induce Cre activation to permanently label
Wnt11 expressing cells and their descendents. By analyses of
embryos shortly after tamoxifen-induction, we can establish a
high-resolution expression map of Wnt11-CreER and compare it
with the existing in situ data. Alternatively, we can trace the fate of
Wnt11-CreER expressing cells by collecting and analyzing embryos
after a more extended period.
In the current study, we focused on using ourWnt11-CreER BAC
transgene to perform detailed expression and lineage analyses
during gastrulation and heart development. Our results uncovered
strikingly speciﬁc and dynamic expression ofWnt11 in progenitors
of the endodermal and endothelial lineages during early and mid-
gastrulation. In the heart, we demonstrated that not only did the
Wnt11-CreER expressing cells contribute to the three major cardiac
lineages (the endocardium, myocardium and epicardium), but
they did so in a highly spatio-temporally controlled fashion.
Collectively, our results provide novel and signiﬁcant insights
and open up multiple avenues to explore the involvement of
Wnt11/PCP signaling during early endoderm development, vascu-
logenesis and heart formation.
Materials and methods
Cloning and BAC recombineering to generate Wnt11-CreER BAC
transgenic mice
To create an efﬁcient system to target the tamoxifen-inducible
CreER T2 into BACs, we cloned the CreER T2 fragment into the
pIGCN21 vector, in front of an Frt-kanamycin (kan)-Frt cassette that
contains an EM7 promoter to drive kan transcription in bacteria.
BAC clone RP23-122D14 was acquired from BACPAC Resource
Center at Children's Hospital Oakland Research Institute. This
196.9 kb BAC contains the 19.6 kb mouse Wnt11 locus as well as
102.7 kb genomic sequence 50 and 74.5 kb genomic sequence 30 of
Wnt11 (Fig. 1A). To target CreER T2 into the Wnt11 region, CreER
T2-Frt-kan-Frt cassette was ampliﬁed using primers Wnt11-CreER F
(GCGGTGGCCTGCAGGCGGCGGAGTTCGGTGCGGCTCCTGCAGGGTG-
CGACCCCCGGGAGCGCCGGGCGCGCGCGACGATGTCCAATTTACTGA-
CCGTA) and Wnt11-CreER R (TCGCAGATTTTGGTGGGCTCACC-
CAACCTCTCCAGCTTCTCGCCCAATGGCCCATTGGAGTGAAAACGGAG-
TCCTACTCTATTCCAGAAGTAGTGAGGA) to add 78 bp homology
arms on each end. RP23-122D14 BAC DNA was puriﬁed and
electroporated into EL250 cells, and standard BAC recombineering
procedures (Lee et al., 2001) were carried out using the Wnt11
CreER T2-Frt-kan-Frt targeting cassette. LB agar plates containing
12.5 mg/ml chloramphenicol and 25 mg/ml kanamycin were used to
select for successfully targeted clones. PCR and sequencing reac-
tions were performed to conﬁrm that CreER T2 was properly
targeted into the Wnt11 locus. Since EL250 cells also contain
arabinose-inducible Flpe (Lee et al., 2001), the Frt ﬂanked kan
could also be deleted. The resulting Wnt11-CreER T2 BAC DNA was
puriﬁed and used for pro-nuclear injection to create Wnt11-CreER
transgenic founders.
Syntenic analysis of the vertebrate Wnt11 genes
Genetic elements surrounding the Wnt11 locus in mouse and
its homologs in other vertebrate, namely human, chicken, zebra-
ﬁsh and Xenopus were identiﬁed using the UCSC genome browser,
the zﬁn genome browser and the xenbase genome browser for
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each of the organisms, respectively. Conservation analysis across
the Wnt11 locus spanning the Wnt11 containing BAC clone RP23-
122D14 region was performed using the NCBI comparative geno-
mic analysis tool on the dcode/ECR browser.
Mouse strains and genotyping
Wnt11‐CreER BAC transgenic mice were genotyped by PCR
using primers CreA1 (CCG GGC TGC CAC GAC CAA) and CreA2
(GGC GCG GCA ACA CCA TTT TT). Rosa26-tdTomato (B6;129S6-Gt
(ROSA)26Sortm9(CAG‐tdTomato)Hze/J) (R26R‐tdTomato) and Rosa26-lacz
(B6.129S4-Gt(ROSA)26Sortm1Sor/J) (R26R-lacZ) Cre reporter mice
were obtained from the Jackson Laboratory and genotyped as
described (Madisen et al., 2010; Soriano, 1999). All strains were
maintained in a C57B6/SJL/FvB mixed background. Animal care and
use was in accordance with NIH guidelines and was approved by
the Animal Care and Use Committee of the University of Alabama
at Birmingham.
Tamoxifen administration, embryo collection, imaging and X-gal
staining
Wnt11-CreER mice were crossed with Rosa26-Cre reporter
(R26R-LacZ and R26R-tdTomato) mice to obtain Wnt11-CreER;
R26R embryos. Pregnant dams were singly gavaged with tamox-
ifen (Sigma, T-5648, dissolved to 10 mg/ml in corn oil) at 2–6
mg/40 g body weight. Embryos were retrieved 6 h to 6 days post
gavage and the yolk sac was retained for PCR genotyping. Embryos
were temporarily ﬁxed in 4% paraformaldehyde (PFA) at 4 1C for
20–60 min depending on embryo stage and subsequently stored in
PBS. X-gal staining was performed using as a standard protocol as
previously described (Nagy et al., 2007). Bright-ﬁeld and epi-
ﬂuorescent whole mount embryo images were captured using a
Leica MZ16FA ﬂuorescence stereomicroscope equipped with a
multi-ﬂuorescent ﬁlter set and a DFC490 CCD camera.
Immuno-staining and in situ hybridization
Fixed embryos/tissues were processed through sucrose gradi-
ents and embedded in OCT (Tissue-Tek/Sakura, Torrance, CA) for
cryo-sectioning. Brieﬂy, OCT embedded samples were cryo-
sectioned at 10–25 mm, air-dried at room temperature, ﬁxed with
4% PFA, permeabilized with PbTX (0.1% Tween in PBS), incubated
in blocking solution (PbTXþ1% BSA) followed by incubation with
primary antibodies overnight at 4 1C. Sections were washed with
PbTx the next day, incubated with appropriate secondary anti-
bodies for 1 h at room temperature followed by washing with
PbTx and mounting in Vectashield mounting medium containing
DAPI (Vector Labs, Burlingame, CA). Primary antibodies used were
mouse anti-MF20 (sarcomeric myosin heavy chain) (1:15, DSHB,
Iowa) and anti-CD31(PECAM) (1:200, clone MEC 13.3, BD Bios-
ciences, San Jose, CA). Alexa Fluor 647-conjugated donkey anti-
mouse IgG (1:500, Invitrogen, Carlsbad, CA), Dylight-488 conju-
gated donkey anti-mouse IgG, FITC conjugated Donkey anti-rat IgG
(1:400 and 1:200, Jackson ImmunoResearch, West Grove, PA)
and HRP-conjugated goat anti-rat IgG (1:200, SCBT, Dallas, TX)
were used as secondary antibodies. A tyramide signal ampliﬁca-
tion kit (PerkinElmer, Covina, CA, #NEL741E001KT) was used for
Fig. 1. Generation and characterization of Wnt11-CreER BAC transgene. (A) Schematic diagram of BAC clone RP23-122D14 that contains the 19.6 kb mouse Wnt11 locus, and
102.7 kb and 74.5 kb genomic sequence ﬂanking the 50 and 30 ends of Wnt11, respectively. (B, C) A CreER-T2 targeting cassette was used to partially replace the ﬁrst coding
exon (exon3) ofWnt11 by BAC recombineering to create the tamoxifen-inducible Wnt11-CreER BAC transgene. (D–I)Wnt11-CreER BAC transgenic mice were crossed with Cre
reporter R26R-LacZ and the expression pattern of Wnt11-CreER was determined by X-gal staining to examine Cre-induced LacZ expression 6–12 h after tamoxifen injection.
(D) When tamoxifen was injected at E6.25 and X-gal staining was performed 6 h later at E6.5, labeled cells were observed in the proximal extra-embryonic region near the
ectoplacental cone, and in the posterior region of the embryo adjacent to the embryonic/extraembryonic border and the primitive streak. (E–G) Tamoxifen injection at E7.25
and X-gal staining at E7.5 resulted in labeled cells in the node (arrows in (E–G)) and the posterior end of the embryo, surrounding the primitive streak and at the base of the
allantois. (H, I) Tamoxifen administration at E9.0 and X-gal staining at E9.5 resulted in labeled cells in the posterior trunk/tailbud region and the nephric duct (ND, arrow in I)
and in the outﬂow tract and the second pharyngeal arch anteriorly (H). A (anterior); EPC (ectoplacental cone); HT (heart tube); ND (nephric duct (ND); P (posterior); PM
(pharyngeal mesoderm).
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anti-CD31 detection. All ﬂuorescent confocal images were acqui-
red with an Olympus FV1000 Laser Confocal Scanning microscope
and were subsequently analyzed using the FV10-ASW software.
Images were compiled and linearly adjusted for brightness, con-
trast and color balance using Adobe Photoshop CS5. Whole-mount
in situ hybridization was carried out with a standard protocol
(Wilkinson and Nieto, 1993) using a previously described Wnt11
anti-sense probe (Zhou et al., 2007). Fluorescent in situ hybridiza-
tion on sections was carried out as previously described (Wang et
al., 2002) with a tyramide signal ampliﬁcation kit.
Results
Generation of Wnt11-CreER BAC transgene
We identiﬁed a 197 kb BAC clone (RP23-122D14) that con-
tained the 19.6 kb mouse Wnt11 locus as well as 102.7 kb and
74.5 kb genomic sequence 50 and 30 ofWnt11, respectively (Fig. 1A;
Suppl. Fig. S1). To establish an efﬁcient system to target the
tamoxifen-inducible CreER T2 into the BAC, we ﬁrst created a
construct in which CreER T2 was linked to an Frt ﬂanked kanamy-
cin (kan) cassette (Fig. 1B). This cassette allows direct selection of
kan resistant clones that have also co-incorporated CreER T2
through BAC recombineering, and can be deleted by induction of
ﬂpe activity in EL250 cells that harbor an arabinose-inducible ﬂpe
(Lee et al., 2001).
Using PCR, we added 78 bp homology arms at each end of the
CreER T2-Frt-kan-Frt cassette to target it into the Wnt11 locus in
the BAC. The inserted CreER T2 replaced part of the ﬁrst coding
exon of Wnt11, exon3, from the ATG start codon to the splicing
donor sequence immediately behind exon3 (Fig. 1B). The resulting
Wnt11-CreER BAC, therefore, would express CreER T2 under the
control of Wnt11 promoter and regulatory sequences, but was
expected not to produce Wnt11 protein due to the deletion of the
start codon in exon3 (Fig. 1C). Moreover, even if a truncatedWnt11
transcript could be made and a cryptic start codon could be used
to initiate translation, we predict that no functional Wnt11 ligand
can be made from Wnt11-CreER BAC transgene owing to the
deletion of the ﬁrst 83 codons in exon3, which encode the signal
peptide required for Wnt11 secretion.
Establishment and characterization of a Wnt11-CreER transgenic line
We established one transgenic line from pronuclear injection of
the Wnt11-CreER BAC DNA. To determine how faithfully the
transgene could recapitulate endogenous Wnt11 expression, we
ﬁrst analyzed the spatial pattern of Wnt11-CreER expression at
several embryonic stages. This was achieved by crossing Wnt11-
CreER mice with Rosa26 Cre reporter (R26R-LacZ) mice to visualize
Cre-activated reporter gene (LacZ) expression shortly (6–12 h)
after tamoxifen administration, which allowed transient nuclear
translocation of Cre to induce homologous recombination and
activate Cre reporter expression.
When we performed tamoxifen administration by oral gavage
at E6.25, and dissected and stained embryos with X-gal 6 h later
(E6.5), we observed LacZ-positive cells in the proximal extra-
embryonic region near the ectoplacental cone (EPC), and in the
posterior region of the embryo proper, adjacent to the primitive
streak at this stage (Fig. 1D). This pattern closely resembled the
reported endogenous Wnt11 gene expression at E6.5 revealed by
in situ hybridization (Kispert et al., 1996). Tamoxifen induction at
E7.25 and X-gal staining 6 h later at E7.5 resulted in labeled cells in
the node and the posterior end of the embryo, around the
primitive streak and at the base of the allantois (Fig. 1E-G)). This
pattern again mimics E7.5 Wnt11 in situ results (Kispert et al.,
1996) (Suppl. Fig. S2). Lastly, when we injected tamoxifen at E9.0
and stained the embryos 12 h later at E9.5, we observed labeled
cells in the posterior trunk/tailbud region and in the nephric duct
(Fig. 1I). Anteriorly, labeled cells are found primarily in the OFT and
the second pharyngeal arch, where second heart ﬁeld (SHF)
progenitors are located (Fig. 1H). The pattern of the labeled cells
also closely matched Wnt11 in situ hybridization studies per-
formed at E9.5 (Kispert et al., 1996; Zhou et al., 2007).
Collectively, our analyses of CreER induced LacZ expression
shortly after tamoxifen induction indicate that the Wnt11-CreER
BAC transgene can largely recapitulate endogenous Wnt11 expres-
sion during early mouse development.
Cells expressing Wnt11-CreER during gastrulation contribute to
speciﬁc endodermal and mesodermal tissues in the embryonic
and extra-embryonic compartments
Given that Wnt11-CreER expressing cells appeared to occupy
distinct domains during gastrulation (Fig. 1D–F), we ﬁrst sought to
determine which lineages they would contribute to by performing
long term lineage tracing (2–6 days) after a single tamoxifen
adminstration, either before gastrulation (E5.5 and earlier) or at
the early (E6.0), mid (E6.5) or late (E7.5) streak stages. For long
term tracing experiments, we utilized the ﬂuorescent Rosa26 Cre
reporter, R26R‐tdTomato. R26R‐tdTomato was constructed similarly
as R26R-LacZ except that Cre-mediated recombination led to the
permanent expression of tdTomato, a fast maturing, remarkably
bright and photo-stable red ﬂuorescent protein (Madisen et al.,
2010; Shaner et al., 2007). These properties of tdTomato allowed
direct and instantaneous visualization of labeled cells upon
embryo dissection, and eliminated potential problems with LacZ
staining in older embryos. Furthermore, co-immunoﬂuorescent
staining could be performed to determine the identity of the
tdTomato positive cells.
Activation of Wnt11-CreER prior to gastrulation (E5.5 or earlier)
When pregnant dams were induced with tamoxifen at E5.5 or
earlier and embryos were collected at E8.5 or later, only a few
labeled cells were detected that were scattered around the
embryos with no consistent pattern (data not shown). This result
indicated that Wnt11-CreER was not expressed at signiﬁcant levels
prior to the onset of gastrulation in mice.
Activation of Wnt11-CreER at the early streak stage (E6.0)
Interestingly, when we administered a single dose of tamoxifen at
E6.0, we found that Wnt11-CreER expressing cells contributed to
speciﬁc lineages in both the extra-embryonic and embryonic
regions. Most strikingly, when these E6.0 tamoxifen-induced
embryos were harvested at E8.25 (Fig. 2A and B – whole mount),
the tdTomato labeled cells occupied almost the entire embryonic
endoderm along the anterior–posterior axis (Fig. 2F, G and J).
Secondly, we found that in E6.0 tamoxifen-induced embryos
harvested at E8.25, a small number of tdTomato labeled cells also
co-expressed the endothelial marker PECAM (Platelet endothelial
cell adhesion molecule) (green arrows in Fig. 2F, F0, J and J″). In the
extra-embryonic region, these tdTomato/PECAM double positive
cells were present as a few small clusters in the yolk sac (green
arrows in Fig. 2J and J″); whereas in the embryo proper, these cells
were located along the dorsal aorta (green arrows in Fig. 2F
and F0).
Overall, these results indicated that at the onset of gastrulation,
Wnt11-CreER was expressed in the progenitors of the entire
embryonic endoderm and a small portion of the endothelial
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mesoderm that would give rise to the vasculature in both the
embryonic and extra-embryonic compartments.
Activation of Wnt11-CreER at the mid streak stage (E6.5)
Embryos induced at E6.5 and harvested at E8.5 resulted in tdTomato
labeling of a majority of endodermal cells along the entire A–P axis
(Fig. 3), similar to E6.0-tamoxifen induced embryos (Fig. 2). Since
the endoderm is known to give rise speciﬁcally to the epithelial
lining of the respiratory and the digestive systems (Zorn and Wells,
2009), we also performed longer term tracing to determine the
developmental potential and speciﬁcity of these tdTomato-labeled
cells. When we retrieved E6.5-tamoxifen induced embryos at E12.5,
we observed that tdTomato expressing cells colonized most of the
endoderm-derived internal organs including the trachea, esopha-
gus, lung, stomach and intestines (Fig. 4E, E0, G, G0 and data not
shown). Sectioning of these organs further conﬁrmed that tdTomato
labeled cells were present almost exclusively in the epithelial
linings of these organs (Fig. 4F, F″, H and H″).
Fig. 2. Cells expressingWnt11-CreER at the onset of gastrulation contribute to the endodermal and endothelial lineages.Wnt11-CreERmediated recombination and activation
of tdTomato expression were induced by a single dose of tamoxifen administration at E6.0, and embryos were harvested and analyzed at E8.5. (A) Epi-ﬂuorescence of
tdTomato alone, and (B) merged with brightﬁeld. Saggital (C–F0) and transverse (G–J″) sections of the embryos co-stained with DAPI (nucleus) revealed that tdTomato
expressing cells (red) were present along the endoderm from anterior (F and magniﬁed view in F0 , red arrows) to the posterior (F, J and magniﬁed view in J0). A small number
of tdTomato expressing cells also co-expressed the endothelial marker PECAM (D, F H, J and J″) and were present in the dorsal aorta in the embryo proper (green arrow in F;
magniﬁed in F0) and as a few clusters in the yolk sac vasculature (green arrow in J; magniﬁed in J″). The dotted line in (B) indicates the plane of sectioning in G–J″. ant NT
(anterior neural tube); DA (dorsal aorta); En (endoderm endoderm); Post. en (posterior endoderm); post NT (posterior neural tube); YSV (yolk sac vasculature).
Fig. 3. Cells expressingWnt11-CreER at the mid streak stage contribute to the endodermal and mesodermal lineages.Wnt11-CreERmediated recombination and activation of
tdTomato expression were induced by a single dose of tamoxifen administration at E6.5, and embryos were harvested and analyzed at E8.5. (A, B) Epi-ﬂuorescence of
tdTomato alone, and (A0 , B0) merged with brightﬁeld. (C–F) Embryo sections co-stained with PECAM (green) and DAPI (blue) revealed that tdTomato (red) expressing cells
occupied many more patches of the vasculature in the yolk sac (C) and the allantois (F) when compared to E6.0 tamoxifen induced embryos (Fig. 2F). Increased contribution
of tdTomato expressing cells to the endothelial lineage was also evident in the dorsal aorta (green arrows in (D) and (D0)). TdTomato expressing cells also occupied the entire
endoderm, from the anterior to the posterior endoderm (red arrows in (C) and (E)). Dotted lines in (A0) and (B0) indicate the plane of sectioning in (C–E). ant NT (anterior
neural tube); DA (dorsal aorta); FG (foregut); post NT (posterior neural tube); YSV (yolk sac vasculature).
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Compared to the E6.0-tamoxifen induced embryos, the E6.5-
tamoxifen induced Wnt11-CreER; R26R-tdTomato embryos harvested
at E8.5 had greater number of tdTomato labeled cells contributing to
the endothelial lineage. In the embryo proper, more tdTomato-
expressing cells could be observed in the dorsal aortae (compare
Fig. 3D0 to Fig. 2F0). This trend was even more evident in the extra-
embryonic region, where tdTomato labeled cells occupied many
more patches of the vasculature in the yolk sac (Fig. 3A–C) and the
allantois (Fig. 3F). When these E6.5-tamoxifen induced embryos
were harvested at E12.5, we found many tdTomato positive cells
lining the blood vessels in the yolk sac (Fig. 4A and B″) and co-
expressing the endothelial marker PECAM. A large numbers of
tdTomato-expressing cells could also be found in the allantois-
derived tissues in the placenta, including the fetal vasculature in
the labyrinth (Fig. 4C–D″) and the supporting chorio-allanatoic
mesenchyme (yellow arrows in Fig. 4D and D″) at the base of the
placenta.
Endocardium is a specialized layer of endothelial cells lining
the myocardium of the heart. In E6.5 tamoxifen-induced Wnt11-
CreER; R26R-tdTomato embryos harvested at E8.5, we found that
tdTomato-expressing cells also contributed extensively to the
endocardium (Fig. 7A, B and B0). We will discuss this ﬁnding in
more detail in the later sections where we examined the dynamic
contribution of Wnt11-CreER cells to the heart.
Activation of Wnt11-CreER at the late streak stage (E7.5)
To assess the expression of the Wnt11-CreER transgene at the late
primitive streak stage, we administered tamoxifen at E7.5 and
Fig. 4. Contribution of E6.5 Wnt11-CreER expressing cells to the endothelium and endodermally derived internal organs in E12.5 embryos. Wnt11-CreER mediated
recombination and activation of tdTomato expression were induced by a single dose of tamoxifen administration at E6.5, and embryos were harvested and analyzed at E12.5.
(A–D″) Whole mount epi-ﬂuorescent analysis showed that tdTomato expressing cells line the yolk-sac vasculature (A and A0), and co-expressed the endothelial marker
PECAM (B, B0 and B″). Bisection of the placenta revealed widespread tdTomato expression in the placental labyrinth (C and C0). In the placenta, tdTomato expression was
present mainly in the endothelial cells in the fetal vasculature (D0 and D″) as well as the supporting chorio-allanatoic mesenchyme (yellow arrows in D and D″) surrounding
the larger placental vessels. (E–H″) In the embryo proper, tdTomato expressing cells contributed to the endodermally derived internal organs, namely the lungs and the
gastro-intestinal tract. (E, E0 , G, G0) Whole mount epiﬂuorescent analysis. Sectioning along the indicated planes in E0 and G0 (dashed white lines) revealed that the tdTomato
expressing cells were present mostly in the epithelial lining of the lungs (white arrows in F and F0; magniﬁed view in F″) and stomach (white arrow in H and H0; magniﬁed
view in H″). Eso: esophagus, GIT: gastro-intestinal tract.
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retrieved embryos at E8.5–8.75. In these embryos, we continued to
see tdTomato expressing cells in the hindgut endoderm (red
arrows in Fig. 5B and C″) and embryonic vasculature including
the dorsal aortae (green arrows, Fig. 5C″), the inter-somitic vessels
(green arrows, Fig. 5B) and the omphalomesenteric vein (lower
green arrow in Fig. 5C″). When E7.5-induced embryos were
harvested at E12.5, Wnt11-CreER lineages were observed in the
yolk sac and allantoic vasculature, and lining the elaborate fetal
vasculature in the yolk sac (Suppl. Fig. S3A and A0) and placenta
(Suppl. Fig. S3B and B0).
Compared to earlier inductions, inductions at E7.5 resulted in
additional tdTomato-labeling of distinct mesodermal tissues
including the notochordal plate (white arrow in Fig. 5C″), the
posterior intermediate and lateral plate mesoderm (yellow
arrows; Fig. 5C and C″) and the myocardium of the left ventricle
(LV, see later). This is consistent with in situ analyses demonstrat-
ing that endogenous Wnt11 is expressed strongly in the node,
posterior trunk mesoderm and the cardiac crescent (Kispert et al.,
1996) (Suppl. Fig. S2).
Wnt11-CreER expression terminates in the embryonic endoderm
and extra-embryonic vasculature shortly after gastrulation
Our analyses indicated that cells expressing Wnt11-CreER dur-
ing gastrulation (E6.0–7.5) contributed extensively to the endo-
dermal lineage, but endogenous Wnt11 expression was not
detected in the endoderm of E8.5–10.5 mouse embryos (Kispert
et al., 1996). A possible explanation for this apparent discrepancy
is that Wnt11 expression is only transiently activated in endoder-
mal progenitors, but is terminated in their descendents shortly
after gastrulation. To test this hypothesis, we administered tamox-
ifen at E8.5–9.0 and harvested Wnt11-CreER; R26R-tdTomato
embryos between E10.5 and E12.5. Interestingly, we found that
in these E8.5–9.0 tamoxifen induced embryos, no tdTomato
expressing cells were found in the epithelial lining of the fore-,
mid- and hindgut endoderm (white arrows, Fig. 6E–H). In fact,
when we carefully re-examined the embryos induced at E7.5, we
found that although some tdTomato expressing cells could be
found in the midgut (Fig. 6B) and hindgut endoderm (Figs. 5B and
C0 and 6C), they were already absent from the foregut endoderm
(Fig. 6A and D).
Furthermore, we found that in E8.5–9.0 tamoxifen induced
embryos, the contribution of tdTomato expressing cells to the
extra-embryonic vasculature of the yolk sac and placenta was also
diminished (Fig. 6E–H). These results together indicated that
Wnt11-CreER was transiently expressed in the progenitors of the
embryonic endoderm and extra-embryonic endothelium during
gastrulation, but was turned off shortly afterward. This temporal
analysis of Wnt11-CreER transgene during gastrulation also high-
lighted the signiﬁcant advantage of CreER, which enabled us to
determine not only the lineage contribution of Wnt11 expressing
cells with high spatial resolution, but also the speciﬁc timing and
duration of Wnt11 expression in each lineage.
Wnt11-CreER expressing cells contribute to multiple cardiac lineages
in a spatio-temporally regulated manner
The most severe defect in Wnt11 mutant mice is malformation
of the heart (Zhou et al., 2007), which can be further enhanced by
simultaneous mutation of another non-canonical Wnt gene Wnt5a
(Cohen et al., 2012). To more thoroughly understand how non-
canonical Wnt signaling might promote cardiac development, we
used Wnt11-CreER to investigate the speciﬁc spatial and temporal
expression of Wnt11 in each lineage in the heart.
The Wnt11-CreER expression is initiated ﬁrst in endocardial
progenitors and maintained in the differentiated endocardium
The endocardium is a specialized layer of endothelial cells
lining the myocardium. In Wnt11-CreER; R26R-tdTomato embryos
induced at E6.5 and harvested at E8.5, tdTomato-labeled cells
Fig. 5. Cells expressingWnt11-CreER at late streak stage contribute to the posterior endoderm and to distinct mesodermal tissues.Wnt11-CreERmediated recombination and
activation of tdTomato expression were induced by a single dose of tamoxifen administration at E7.5, and embryos were harvested and analyzed at E8.75. (A) Epi-
ﬂuorescence of tdTomato alone, and (A0) merged with brightﬁeld. (B) Saggital section of the embryonic region (yellow box in (A0) revealed the contribution of tdTomato
expressing cell to the endoderm (red arrow in B), the inter-somitic vessels (ISV, green arrows in B), the dorsal aorta (DA) and the posterior lateral plate mesoderm (tdTomato-
positive cells between dorsal aorta and endoderm). (C–C″) Transverse sectioning of these embryos along the dotted line in (A0) and co-staining with nuclear marker DAPI
(blue) and endothelial cell marker PECAM (green) showed that tdTomato expressing cells colonized the posterior lateral plate and intermediate mesoderm (yellow arrows in
C″), the hindgut endoderm (red arrow in (C″)), the notochordal plate (white arrow in C″) and the endothelial lining of the dorsal aortae (paired green arrows in C″) and the
omphalomesenteric vein (lower green arrow in C″). DA (dorsal aortae); HG (hindgut); ISV (inter-somitic vessels); LPM (lateral plate mesoderm); NP (notochordal plate); OV
(omphalomesenteric vein).
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contributed not only to endothelial cells in the embryonic and
extra-embryonic compartments (Fig. 3), but also to the entire
endocardium lining all chambers of the forming heart tube,
including the inﬂow tract (IFT), the LV, the right ventricle (RV)
and OFT (Fig. 7A and A0; green arrows in Fig. 7B and B0). In stark
contrast, however, tdTomato-expressing cells did not contribute
signiﬁcantly to the myocardium in these embryos, and negligible
numbers of tdTomato positive cells were found in the LV myocar-
dium (Fig. 7B and B0, white arrows). Therefore, the earliest onset of
Wnt11 expression in cardiac progenitors appears to be within the
progenitors of the endocardium during mid-gastrulation, and
these Wnt11-expressing endocardial progenitors have already
diverged from myocardial progenitors that will give rise to the
ﬁrst heart ﬁeld (FHF) and SHF.
Unlike the transient expression of Wnt11-CreER in endothelial
progenitors in the extra-embryonic compartment (Fig. 6), Wnt11-
CreER expression in the endocardium persisted for an extended
period. When we performed tamoxifen inductions from E7.0 to
10.5, we continued to detect robust contribution of tdTomato labeled
cells to the endocardium throughout the heart (Fig. 7C–F0). This result
suggests that Wnt11 is expressed not only in early endocardial
progenitors at gastrulation, but continues to be expressed in the
differentiated endocardium within the heart during organogenesis,
and is consistent with expression of endogenous Wnt11 in the
endocardium at E10.5 (Cohen et al., 2012) (Suppl. Fig. S4).
Sequential activation of Wnt11-CreER expression in the progenitors
of the ventricular myocardium
Interestingly, when Wnt11-CreER; R26R-tdTomato embryos were
induced with tamoxifen at different time points between E7.0 and
9.0 and harvested 1–4 days later, we observed a highly dynamic
contribution of tdTomato-expressing cells to the ventricular myocar-
dium. First, when tamoxifenwas administered at E7.0–7.5, tdTomato-
labeled cells contributed extensively to the myocardium in the LV
and the inter-ventricular septum, but not to the myocardium of the
RV, OFT or atrium (Fig. 8A–D, Suppl. Fig. S5A and A0, Suppl. Fig. S6A
and B). This pattern of contribution suggests thatWnt11 is expressed
speciﬁcally in the myocardial progenitors of the FHF at E7.5,
Fig. 6. Wnt11-CreER expression terminates in the embryonic endoderm and the extra-embryonic vasculature shortly after gastrulation. (A–D) In embryos in which a single
dose of tamoxifen was administered at E7.5, the contribution of tdTomato expressing cells to the mid- (B) and hindgut (C) endoderm was reduced, and could no longer be
found in the foregut endoderm (A and D). In contrast, abundant contribution of tdTomato expressing cells could be found in the splanchnic mesenchyme (SM) surrounding
the hindgut (C) and in the vasculature. (E–L) When tamoxifen was administered at E8.5–9.0, tdTomato expressing cells were completely absent from the foregut (white
arrows in E and H), midgut (white arrows in F) and hindgut (white arrow in G) endoderm, but contributed speciﬁcally to the nephric duct (ND in G). The contribution of
tdTomato expressing cells to the extra-embryonic vasculature in the yolk sac and placenta was also diminished. (I) Whole mount epi-ﬂuorescence alone, and (J) merged
image with brightﬁeld revealed no tdTomato expressing cells in the yolk sac. (K and L) Bisection of the placenta revealed that tdTomato expressing cells also could no longer
be found in the fetal vasculature (compare to Fig. 4C–D″). The limited remaining tdTomato expression appeared to be in the extra-embryonic Reichert's membrane. ND
(nephric duct); NT (neural tube); SM (splanchnic mesenchyme).
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consistent with the in situ analysis showing that endogenous Wnt11
is expressed in the cardiac crescent (Kispert et al., 1996).
Subsequently, when we administered tamoxifen at E8.0, we
found that tdTomato-positive cells contributed to both the LV and
the RV myocardium (Fig. 8E and F), but not to the OFT myocardium
(Fig. 8G and H). On the other hand, when tamoxifen was adminis-
tered at E8.5, we found extensive contribution of tdTomato labeled
cells to the RV and OFT myocardium (Fig. 8I and K), but their
contribution to the LV myocardium was diminished (Fig. 8J and L,
Suppl. Fig. S5B and B0).
Finally, when we performed tamoxifen induction at E9.5, we
found that the contribution of tdTomato-positive cells to the RV
myocardium was also diminished (Fig. 8M–P), and upon induction
at E10.5, we could no longer ﬁnd any tdTomato expressing cells in
the myocardium of either ventricles (Fig. 7E and F0). Collectively,
our analyses suggest that Wnt11 is expressed in a highly dynamic
and transient fashion, ﬁrst in FHF precursors that give rise to the
LV myocardium, and then in the SHF progenitors of the RV
myocardium.
Spatially restricted contribution of Wnt11-CreER expressing cells
to the OFT myocardium
When we administered tamoxifen at E8.5 and harvested
embryos at E9.5, we found that in addition to the RV myocardium,
tdTomato expressing cells were also present in the second phar-
yngeal arch mesoderm known to harbor the SHF progenitors of
the OFT myocardium (Kelly et al., 2001) (Fig. 9A and black arrows
in Fig. 9B), and the contiguous superior wall of the OFT myocar-
dium (Fig. 9C). This spatially restricted contribution of Wnt11-
CreER expressing cells to the superior wall of the OFT myocardium
could be visualized also when we collected these E8.5–9.0
tamoxifen-induced embryos at E10.5. Sagittal and transverse
Fig. 7. Wnt11-CreER expression is initiated in the endocardial progenitors during gastrulation and maintained in the differentiated endocardium. (A–B0) Activation of
tdTomato expression by Wnt11-CreER was induced with tamoxifen at E6.5, and embryos were analyzed at E8.5. (A) Whole mount epi-ﬂuorescent image of tdTomato
alone, and (A0), merged with brightﬁeld. (B, B0) Transverse sectioning and co-immunostaining with PECAM revealed that tdTomato expressing cells occupied almost
the entire endocardium lining all chambers of the forming heart tube (outlined by dotted white line), including the inﬂow tract (IFT), the left ventricle and the right
ventricle/OFT. By contrast, only few tdTomato expressing cells could be found in the LV myocardium (white arrows in B and B0). (C, C0) Tamoxifen induction at E7.5
revealed that tdTomato expressing cells contributed exclusively to the endocardium (green arrows in C and C0), but not the myocardium, in the OFT and RV. (D–F0)
When tamoxifen induction was performed at E10.5 and the resulting embryos analyzed at E12.5, tdTomato expressing cells could still contribute to the entire
endocardium of both the right and the left ventricles, indicating that Wnt11-CreER expression was maintained in the differentiated endocardium. In these embryos,
tdTomato expressing cells also contributed to the epicardial layer around the ventricles (yellow arrows in E, E0 , F and F0). en (endocardium); epi (epicardium); IFT
(inﬂow tract); LV (left ventricle); myo (myocardium); OFT (outﬂow tract); RV (right ventricle).
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sectioning and immunostaining with myocardial marker MF20 in
these embryos clearly indicated that tdTomato expressing
cells were present only in the myocardium of the superior
wall of the OFT (white arrow in Fig. 9D–I), but absent from the
inferior ¼ region of the OFT myocardial wall (yellow arrow in
Fig. 9F–I).
The speciﬁc contribution of the Wnt11-CreER lineage to the
superior wall of the OFT myocardium also prompted us to
determine its long-term developmental potential. Previous line-
age tracing studies, using enhancer trap transgene y96-myf5-
nlacz-16 (y96–16) and a set of Hox Cre lines, indicated that cells
initially occupying the inferior wall of the OFT myocardium give
rise speciﬁcally to the cardiomyocytes at the base of the
pulmonary artery (Bajolle et al., 2006; Bertrand et al., 2011;
Theveniau-Ruissy et al., 2008). In contrast, when we performed
longer term tracing, we found that the Wnt11-CreER lineage,
which initially occupied the superior wall of the OFT myocar-
dium, contributed primarily to the cardiomyocytes around the
base of the aorta (arrows in Fig. 9J–O), but not the pulmonary
artery (white dotted lines in Fig. 9J–O).
Therefore, together with the previous literature (Bajolle et al.,
2008; Bertrand et al., 2011; Rochais et al., 2009; Theveniau-Ruissy
et al., 2008), our results indicate that the superior and inferior wall
of the early OFT myocardium are molecularly distinct and pre-
determined to contribute speciﬁcally to the sub-aortic and sub-
pulmonary myocardium, respectively.
Fig. 8. Sequential activation of dynamic Wnt11-CreER expression in the progenitors of the ventricular myocardium. (A–D) When tamoxifen was administered at E7.0 (A, B)
and 7.5 (C, D), tdTomato-labeled cells contributed extensively to the myocardium (MF20 positive, green) in the left ventricle and the inter-ventricular septum, but were
absent from the myocardium of the right ventricle and OFT. (E–H) When tamoxifen was administered at E8.0, tdTomato-positive cells contributed to both the left and the
right ventricular myocardium, but not to the atrial or OFT myocardium (F, H). (I–L) On the hand, when tamoxifen was administered at E8.5, tdTomato labeled cells
contributed to the right ventricular myocardium (K), but their contribution to the left ventricular myocardium became diminished (L). (M–P) Finally, when tamoxifen was
administered at E9.5, the contribution of tdTomato-positive cells to the left (P) and the right (O) ventricular myocardium was diminished. In all the stages analyzed above,
tdTomato positive cells contributed extensively to the endocardium in all chambers. Additionally, sporadic tdTomato expressing cells were present in the epicardium of
embryos that were tamoxifen-induced at E8.5 (yellow arrow in J). The entire epicardium became tdTomato positive when tamoxifen was administered at E9.5 (yellow arrows
in M–P). Insets in K, L, O and P show a magniﬁed view of tdTomato expressing cells and MF20 positive myocardium. en (endocardium); epi (epicardium); IFT (Inﬂow tract);
LV (left ventricle); myo (myocardium); OFT(outﬂow tract); RV (right ventricle).
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Wnt11-CreER lineages contribute to the epicardium
In addition to the myocardium and endocardium, the heart contains a
third lineage known as the epicardium. The epicardium is derived
from cells in the pro-epicardial organ situated over the septum
transversum caudal to the heart tube. Pro-epicardial cells extend and
attach onto the myocardial layer of the forming atria and ventricles
from E9.5 onwards and rapidly spread over the heart to form a
Fig. 9. Spatially restricted contribution of Wnt11-CreER expressing cells to the OFT myocardium. (A–C) Whole mount epi-ﬂuorescent analysis showed that when tamoxifen
was administered at E8.5; in the resulting E9.5 embryos, tdTomato expressing cells were largely present in the mesoderm of the second (2nd) pharyngeal arch (black box in A
and magniﬁed view in B), the myocardium of the OFT superior wall and the right ventricle (blue box in A and magniﬁed view in C), and the endocardium of the OFT, RV and
IFT. (D–I) When embryos were harvested at E10.5 after tamoxifen induction at E9.0, tdTomato expressing cells were observed along the proximo-distal axis of the superior
myocardial wall of the OFT (white arrow in D and F), which also co-expressed myocardial marker MF20. Transverse section of the OFT (G–I) indicated that the tdTomato
expressing cells occupied 3/4 of the superior and lateral OFT myocardial wall and were missing from the inferior OFT wall (white dotted line in G–I). When E9.0 tamoxifen
induced embryos were harvested at E12.5, transverse sectioning and co-staining with MF-20 indicated that tdTomato labeled cells were present speciﬁcally in the sub-aortic
myocardium (white arrows in J, L, M and O), but were absent from the sub-pulmonary myocardium (white dotted lines in J–O). In contrast, co-staining with PECAM indicated
that tdTomato labeled cells contributed to the endocardium/endothelium in both the aorta and pulmonary artery. Ao (aorta), BA (branchial arch); en (endocadium); IFT
(inﬂow tract); OFT (outﬂow tract); PA (pulmonary artery); PhA (pharyngeal arch); RV (right ventricle).
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contiguous epicardial layer covering the entire myocardium by E11.5
(Rodgers et al., 2008).
When tamoxifen was administered at E8.5 or earlier, we detected
only few tdTomato-expressing cells in the epicardial layer (yellow
arrow in Fig. 8F). However, when tamoxifen induction was per-
formed at E9.5 (Fig. 8I–P), E10.5 (Fig. 7E, F, G and H) or later (Suppl.
Fig. S7 and data not shown), the entire epicardial layer consisted of
tdTomato-expressing cells. Consistent with our Wnt11-CreER analysis
in the epicardium, a previous report by Cohen et al. (2012) and our
in situ analyses (Suppl. Fig. S4) showed endogenous Wnt11 tran-
scripts in the epicardium of the developing heart.
Collectively, as summarized in Table 1, our lineage analyses
with the Wnt11-CreER BAC transgene has provided a high-
resolution expression and fate map of Wnt11 expressing cells in
the heart. WhereasWnt11-CreER expression in the endocardial and
epicardial lineages is more persistent and present throughout all
chambers of the heart, its expression in the myocardium is highly
dynamic and present only transiently and successively in precur-
sors of the LV, RV and OFT myocardium. Notably, the only regions
where we detected no contribution of Wnt11-CreER expressing
cells were the atrial myocardium (Suppl. Fig. S6) and the inferior
wall of the OFT myocardium (Fig. 9D–I).
Discussion
In recent years, the PCP pathway has been recognized as a key
signaling mechanism that regulates tissue morphogenesis in
diverse animal species, and has garnered attention from investi-
gators across different disciplines. Activation of PCP-mediated
morphogenetic processes requires non-canonical Wnts as ligands,
and Wnt11 has been identiﬁed as one of the primary PCP ligands
during zebraﬁsh and Xenopus gastrulation (Heisenberg et al.,
2000; Li et al., 2008; Schambony and Wedlich, 2007; Tada and
Smith, 2000; Walentek et al., 2013). The potential role of Wnt11 as
a PCP ligand in mammals, however, has remained less clear
because Wnt11 mutant mice do not display some of the character-
istic phenotypes observed consequent to mutation of core PCP
genes Vangl2, Dvl and Celsr. Phenotypic differences may be due to
altered expression patterns during evolution, or redundancy of
other non-canonical Wnts. Therefore, expression maps with high
spatial and temporal resolution need to be established for mam-
malian non-canonical Wnt genes. Secondly, whereas PCP signaling
is best known for regulating gastrulation in zebraﬁsh and Xenopus,
its function in mammals has only been found in neurulation and
development of speciﬁc organs, and its involvement in mamma-
lian gastrulation has not been examined extensively.
In the current study, we attempted to establish a framework to
further explore the role of Wnt11 in mammalian gastrulation, by
generating both a high-resolution expression map of Wnt11 and a
fate map of Wnt11 expressing cells. To this end, we created a
tamoxifen-inducible Wnt11-CreER BAC transgene in the mouse.
Analysis of this transgene over the course of gastrulation uncov-
ered surprisingly dynamic and speciﬁc expression of Wnt11 in the
progenitors of the endodermal, endothelial and cardiac lineages,
which had not been recognized from previous in situ studies.
These experiments indicate that at the early streak stage (E6.0),
Wnt11-CreER expression is initiated primarily in the progenitors of
the endoderm, expands progressively to the mesodermal progeni-
tors of the endothelial/endocardial lineage at the mid streak stage
(E6.5), and ﬁnally to the distinct mesoderm of the cardiac,
notochord, posterior intermediate and lateral plate lineages by
E7.5. The timing of Wnt11-CreER expression in the endoderm and
mesoderm suggests that these lineages may sequentially activate
Wnt11 expression as they transit the primitive streak during
gastrulation, suggesting a potential role for Wnt11-initiated sig-
naling in egression of progenitors during germ layer formation.
A Wnt11-CreER BAC transgene faithfully recapitulates endogenous
Wnt11 expression
Due to their large size, BAC transgenes have been known to
recapitulate endogenous gene expression patterns (Lee et al.,
2001). The BAC clone we used to create Wnt11-CreER transgene
contained 75–100 kb genomic sequence ﬂanking each end of the
mouse Wnt11 locus. Our analyses of CreER-induced reporter gene
expression shortly after a pulse of tamoxifen revealed that Wnt11-
CreER expression closely mimicked the reported endogenous
Wnt11 expression from gastrulation to mid-gestation (Fig. 1 and
Kispert et al. (1996)). Our longer term tracing experiments further
revealed expression of Wnt11-CreER in tissues such as the endo-
cardium, epicardium, and nephric duct (Figs. 6C, 7 and 8), in which
expression of endogenous Wnt11 has also been reported (Cohen et
al., 2012; Kispert et al., 1996). Finally, the same BAC clone (RP23-
122D14) used in our study was also used to create a separate
Wnt11-Cre BAC transgenic line (Wnt11-myrTagRFP-IRES-CE) as part
of the GUDMAP Consortium (the GenitoUrinary Development
Molecular Anatomy Project). Although the analyses of Wnt11-
myrTagRFP-IRES-CE focus on genito-urinary development, and its
expression during early embryogenesis has not been reported
(https://www.gudmap.org/Docs/Mouse_Strains/18_Wnt11_allele_
characterisation.pdf), its ability to faithfully recapitulate endogen-
ous Wnt11 expression in the developing mesonephros between
E11.5–15.5 supports the idea that the BAC clone RP23-122D14
contains most of the elements required to regulate Wnt11
Table 1
Summary of the spatio-temporally speciﬁc contribution of the Wnt11-CreER expressing cells to the embryonic heart: Cre activity was transiently induced in Wnt11-CreER;
R26R-tdTomato embryos by a single tamoxifen administration at E6.5–10.5, and embryos were harvested and analyzed at E8.5–12.5 to determine the contribution of
tdTomato labeled cells to the epicardium, myocardium and endocardium of the left ventricle (LV), right ventricle (RV), outﬂow tract (OFT) and atrium (A). The (þ) and ()
indicate the presence and absence of tdTomato expressing cell in each compartment, respectively, with (þþþ) indicating highest levels of tdTomato expressing cells
present.
Tamoxifen administration (Embryonic Day-E) Dissection (Embryonic Day-E) Myocardium Endocardium Epi-cardium
LV RV OFT A LV RV OFT A
6.5 8.5 – – – – þþ þþ þþ þþ –
7.0 9.0 þþ – – – þþþ þþþ þþþ þþ –
7.5 9.5/10.5 þþþ – – – þþþ þþþ þþþ þþ –
8.0 9.5 þþ þþ þ/ – þþþ þþþ þþþ þþ –
8.5 12.5/16.5 þ þþþ þþ – þþþ þþþ þþþ þþ þ
9.0 10.5/12.5 þ/ þþ þþþ – þþþ þþþ þþþ þþ þþ
9.5 12.5 – þ þþ – þþþ þþþ þþþ þþ þþþ
10.5 12.5 – – þ – þþþ þþþ þþþ þþ þþþ
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expression. Therefore, we predict that the expression and lineage
tracing analyses performed in gastrulation stage embryos with our
Wnt11-CreER transgene reﬂect endogenous Wnt11 expression.
However, since the Wnt11-CreER BAC transgene is a random
insertion, it remains possible that some of its expression domains
may not reﬂect those of endogenous Wnt11. Therefore, the
observations and conclusions that we have made in the current
study can be further validated with the Wnt11-myrTagRFP-IRES-CE
BAC transgene in the future.
Transient expression of Wnt11 in endodermal progenitors during
early gastrulation
Coordinated morphogenetic movements during gastrulation
result in the establishment of the three germ layers: the endoderm,
mesoderm and ectoderm. At the onset of zebraﬁsh gastrulation,
Wnt11 is expressed in the epiblast around the germ ring and
activates PCP signaling in ingressed/involuted mesendodermal cells
to enable their directed migration (Ulrich et al., 2003). Together
with its closely related homolog Wnt11-r (Wnt11-related) and
Wnt4, Wnt11 also activates PCP signaling in endoderm precursors
to promote their migration toward the midline and fusion of the
foregut (Matsui et al., 2005).
Similar to the zebraﬁsh, in Xenopus, XWnt11 expression is
initiated in the superﬁcial layer of the involuting marginal zone
(IMZ) at the onset of gastrulation, starting from the dorsal region
and gradually spreading laterally to surround the entire blastopore
(Walentek et al., 2013). Involution of this superﬁcial IMZ layer
gives rise to both the endoderm and mesoderm (Fukuda and
Kikuchi, 2005; Keller, 1975; Shook et al., 2004), suggesting that
like zebraﬁsh, Xenopus Wnt11 is also produced by endodermal and
mesodermal progenitors to regulate their movement during gas-
trulation (Li et al., 2008; Schambony and Wedlich, 2007; Tada and
Smith, 2000; Walentek et al., 2013).
In the mouse, in situ analysis indicated that at the onset of
gastrulation (E6.0–6.5),Wnt11 is expressed in scattered cells in the
posterior part of the embryo around the primitive streak (Kispert
et al., 1996). The identity and fate of these cells, however, were
unknown. In our short-term tracing experiments, we found that
the Wnt11-CreER transgene faithfully recapitulated this scattered
expression pattern around the primitive streak (Fig. 1D). Most
interestingly, our long-term tracing experiments revealed that
these Wnt11-expressing cells were predominantly progenitors of
the embryonic endoderm (Figs. 2–4). Their scattered distribution
around the primitive streak suggests that Wnt11 expression may
be initiated either in the epiblast cells prior to traversing the
organizer (primitive streak) as in zebraﬁsh and Xenopus, or in the
speciﬁed endodermal cells that have exited the primitive streak.
More detailed expression and marker analyses will need to be
performed in the future to address this question. In either case, the
Wnt11-CreER transgene will be a useful tool for time-lapse imaging
to track and investigate cellular behaviors that underlie the
morphogenesis of endodermal lineage.
In Xenopus, Wnt11 is also expressed later in the foregut
endoderm progenitors at the neurula stage, and this phase of
Wnt11 expression is proposed to act through both the canonical
Wnt pathway to suppress the foregut fate and the non-canonical
pathway to promote foregut morphogenesis (Li et al., 2008). In
contrast, our analyses with the Wnt11-CreER transgene suggest
that Wnt11 expression in the mouse endodermal lineage is only
transient, and is largely diminished in foregut endoderm progeni-
tors by late gastrulation at E7.5. Whether the transient expression
of Wnt11 contributes to mouse endoderm development by pro-
moting its gastrulation movement, morphogenesis or speciﬁcation
needs to be determined in the future. Wnt11 null mice die
between E12.5 and P2 and analysis of their endodermal
development has not been reported (Majumdar et al., 2003;
Nagy et al., 2010).
Early Wnt11-expressing mesodermal cells contribute to
the endothelial lineage
Studies in Xenopus indicate that Wnt11 transcription is acti-
vated directly by Brachyury (Xbra; T in mammals), an evolutiona-
rily conserved transcription factor that confers mesodermal
identity to the epiblast. Consequently, Wnt11 and Xbra expression
patterns were described to overlap almost completely in Xenopus
(Tada and Smith, 2000). Intriguingly, although the Xbra ortholog T
is highly expressed in the primitive streak during gastrulation in
the mouse (Inman and Downs, 2006), in situ studies do not detect
signiﬁcant Wnt11 expression in the primitive streak (Kispert et al.,
1996) (Suppl. Fig. S2). Our short term tracing experiments using
Wnt11-CreER also suggest that Wnt11 expression is absent from
the primitive streak (Fig. 1D–F), and our long-term tracing experi-
ments further reveal that throughout gastrulation Wnt11-CreER
expressing cells do not contribute to the paraxial mesoderm,
which T-CreER expressing cells give rise to (Anderson et al.,
2013). Therefore, in contrast to Xenopus, mouse Wnt11 expression
does not seem to be activated broadly by T.
Whereas there is only one Wnt11 in mammals, there are two
Wnt11 genes in zebraﬁsh, Xenopus and chick: Wnt11 and Wnt11-r.
Based on sequence conservation and synteny, it has been proposed
that the two Wnt11 genes arose from an ancient duplication, the
true otholog of ﬁsh/frog Wnt11 was lost in mammals, and the
remaining mammalian Wnt11 is in fact the ortholog of Wnt11-r
(Garriock et al., 2005; Garriock et al., 2007; Hardy et al., 2008). The
lack of mouse Wnt11 expression in the primitive streak and its
strong expression in the cardiac ﬁelds like Xenopus Wnt11-r
strongly support this idea. On the other hand, the expression of
mouse Wnt11 in the endoderm progenitors during early gastrula-
tion appears to resemble that of Xenopus Wnt11 (Tada and Smith,
2000; Walentek et al., 2013), but differs from that of Xenopus
Wnt11-r, which is not initiated until late gastrula (Garriock et al.,
2005). Furthermore, Xenopus Wnt11-r is not expressed in the node,
but both previous in situ studies and our analyses with Wnt11-
CreER reveal speciﬁc expression of mouse Wnt11 in the node
(Fig. 1E and F), where T is expressed (Kispert et al., 1996; Wang
et al., 2006; Yamaguchi et al., 1999b). Therefore, it is likely that in
some contexts, mouse Wnt11 could still be transcriptionally
activated by T, like Xenopus Wnt11. Collectively, these data imply
that whereas Xenopus Wnt11 and 11-r have evolved distinct
expression patterns over time, the sole Wnt11 gene in mammals
has retained some features of both Wnt11 and Wnt11-r, likely
resembling the ancestral Wnt11 prior to gene duplication.
An unexpected ﬁnding from our studies withWnt11-CreER is that
during gastrulation, the ﬁrst group of mesodermal cells expressing
Wnt11 contributes speciﬁcally to the endothelial lineages in the
embryonic and extra-embryonic compartments (Figs. 2–4). This
ﬁnding is important because emerging evidence implicates a critical
role for PCP/non-canonical Wnt signaling in angiogenesis (Cirone
et al., 2008; Descamps et al., 2012; Korn et al., 2014; Masckauchan et
al., 2006; Stefater et al., 2011). Cell culture and zebraﬁsh studies
suggest that PCP signaling induced by non-canonical Wnts coordi-
nates cellular polarity in endothelial cells to promote their migration,
proliferation and survival during angiogenesis (Cirone et al., 2008;
Masckauchan et al., 2006). Mouse genetic studies further reveal that
endothelial cell-derived non-canonical Wnts act in an autocrine
fashion to promote angiogenesis in postnatal retina and in tumors
(Korn et al., 2014). Our analyses with Wnt11-CreER extend these
ﬁndings by showing that Wnt11 is not only expressed in the
endothelial lineage, but more importantly, its onset of expression
occurs at early to mid-gastrulation, when endothelial progenitors
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ﬁrst emerge from the posterior primitive streak. Therefore, our data
raise the intriguing possibility that, in addition to angiogenesis, PCP/
non-canonical Wnt signaling may have earlier roles in endothelial
progenitors prior to or during vasculogenesis, when formation of the
primitive vascular plexus takes place. In support of this idea, mice
lacking Fz2 and Fz7, two Fz receptors thought to signal through the
PCP/non-canonical Wnt pathway, fail to form an organized vascular
plexus by E9.5, and die by E10.5 with the yolk sac engorged with
blood (Yu et al., 2012). In addition to Wnt11, Wnt5a expression has
also been reported in endothelial cells (Ishikawa et al., 2001) and
Wnt11 /; Wnt5a / mutants also die before E10.5 (Cohen et al.,
2012). It will be interesting to determine in the future whether
Wnt11 /; Wnt5a / mutants display vascular abnormalities in
addition to the reported heart defects.
Lastly, the onset of ourWnt11-CreER expression in the endothe-
lial lineage appears to be earlier than the widely used Tie2-Cre
(Kisanuki et al., 2001). With a single dose of tamoxifen adminis-
tration at E6.5, we are able to detect extensive endothelial-labeling
in the embryonic and extra-embryonic vasculature of Wnt11-
CreER; R26R-tdTomato embryos (Figs. 3 and 4). Therefore, this
Cre line can be a valuable tool for visualizing and investigating the
early morphogenetic events associated with vasculogenesis, when
groups of endothelial progenitor cells ﬁrst differentiate and
assemble into a network of small capillary vessels (Udan et al.,
2013).
Wnt11 in heart development
The indispensable role of mammalian Wnt11 in heart develop-
ment and function is clearly demonstrated by the severe heart
defects in Wnt11 / mutants (Cohen et al., 2012; Majumdar et al.,
2003; Nagy et al., 2010; Zhou et al., 2007). Mouse and Xenopus
studies have led to several models as to how Wnt11 functions in
the heart, including establishing proper left-right asymmetry
(Walentek et al., 2013), promoting myocardial speciﬁcation by
antagonizing canonical Wnt signaling (Cohen et al., 2012) or
activating PCP signaling to increase cardiogenic gene expression
(Afouda et al., 2008; Pandur et al., 2002), enhancing cell adhesion
among ventricular cardiomyocytes (Garriock et al., 2005; Nagy
et al., 2010), and activating Tgfβ expression to regulate OFT
morphogenesis (Zhou et al., 2007). Our analyses withWnt11-CreER
revealed highly dynamic expression of Wnt11 in three major
lineages of the heart, and highlight the challenges and potential
approaches to further decipher the role of Wnt11 and non-
canonical Wnt/PCP signaling in mammalian heart formation.
Among the three cardiac lineages, our fate mapping analyses
with Wnt11-CreER indicate that Wnt11 is expressed ﬁrst in the
progenitors of the endocardium. Extensive contribution of
tdTomato-expressing cells to the endocardium was found when
tamoxifen induction was performed at E6.5 (Fig. 7), but their
contribution to the myocardium did not occur until tamoxifen
induction was performed at E7.0 and later (Fig. 8). This result
provides the genetic proof that in mouse, the majority of the
endocardial and myocardial lineages have already diverged by
mid-gastrulation, before they form the cardiac crescent. A similar
conclusion was also reached in the chick by retroviral labeling of
single cells (Wei and Mikawa, 2000). Moreover, in E6.5 tamoxifen-
induced embryos the endothelium can also be labeled together
with endocardium (Figs. 3 and 4). Therefore, the endocardium and
endothelium may arise either from a common pool of progenitors,
as previously proposed (Milgrom-Hoffman et al., 2011), or from
distinct epiblast precursors that happen to be speciﬁed and initiate
Wnt11 expression at about the same time. Time lapse imaging
with Wnt11-CreER embryos will help deﬁne the lineage relation-
ship between the endothelium and endocardium in the future.
In contrast to its persistent expression in the endocardium
throughout all chambers of the heart (Table 1), we found that
Wnt11-CreER expression in the myocardium was highly dynamic
and occurred in three waves: ﬁrst in the precursors of the LV
myocardium from E7.0 to 8.0; subsequently in the RV myocardium
from E8.0 to 9.0; and ﬁnally in the OFT myocardium from E8.5 to
10.5. Its timing of expression coincides with the timing at which
the progenitors in the FHF and SHF undergo myocardial differ-
entiation to form the LV, RV and OFT. The expression pattern of
mouse Wnt11 in the myocardium also resembles that of Xenopus
Wnt11-r (Garriock et al., 2005), but is unlike that of Xenopus Wnt11
which is expressed earlier in the dorsal marginal zone and
promotes cardiac speciﬁcation by activating Nkx2.5 and Gata-4/6
expression in the presumptive mesodermal progenitors (Pandur
et al., 2002).
In Xenopus, the close timing between the onset of Wnt11-r
expression and myocardial differentiation, together with the lack
of myocardial speciﬁcation defect in the Wnt11-r morphant, has
led to the proposal that Wnt11-r may not function by inducing
cardiac speciﬁcation (Garriock et al., 2005). In contrast, mouse
genetic studies have concluded that non-canonical Wnt signaling
is required for myocardial differentiation, sinceWnt11 / mutants
have smaller OFT and RV and Wnt11 /; Wnt5a / mutants
display severe loss of SHF progenitors and SHF-derived heart
structures (Cohen et al., 2012). Given our ﬁnding that Wnt11 is
expressed earlier in the foregut endoderm from E6.0 and the
proximity between the endoderm and the SHF, it remains possible
that endoderm-derived Wnt11 can act in a paracrine fashion to
promote cardiac differentiation in the adjacent SHF progenitors in
the mouse. Consistent with this idea, Xenopus Wnt11 is trans-
criptionally activated directly by Gata4/6 and mediates the cardi-
omyogenic effect of Gata4/6 (Afouda et al., 2008), and in the
mouse Gata4/6 are expressed in the early endoderm (Morrisey et
al., 1998; Rojas et al., 2009; Rojas et al., 2010). Therefore, in the
future it will be important to investigate a potential Gata4/6-
Wnt11 pathway in the early endoderm for cardiac speciﬁcation
and differentiation in mouse.
The highly temporally speciﬁc and transient expression of
Wnt11 within the mouse myocardium is also interesting, and
may have additional implications for the potential functions of
Wnt11 in the heart. For instance, Wnt11 may act in an autocrine
fashion to enhance cell adhesion among cardiomyocytes as Xeno-
pus Wnt11-r (Garriock et al., 2005), and we have found recently
that as SHF progenitors enter the heart tube, they undergo a rapid
up-regulation of cell cohesion (unpublished data, D.L. and J.W.).
Alternatively, Wnt11 may activate PCP signaling to induce the
morphogenetic events required for deploying myocardial progeni-
tors from the SHF to the heart, as we have proposed previously for
another non-canonical Wnt, Wnt5a (Sinha et al., 2012). Further
manipulation of myocardial Wnt11 expression through both gain-
and loss-of-function approaches will help elucidate its role in
heart development and function.
Our analyses indicate that Wnt11 is also expressed in the
epicardial lineage from E9.0 onwards. The functional importance
of this expression is unclear. We note, however, that the ventri-
cular myocardium in Wnt11 / mutants displays reduced cell
adhesion and aberrant cellular arrangement at E10.5–12.5, when
Wnt11 expression within the ventricular myocardium is already
diminished (Fig. 8, (Cohen et al., 2012; Nagy et al., 2010). There-
fore, it is possible that Wnt11 secreted from the epicardium and/or
endocardium can signal to the myocardium to regulate proper
ventricular formation and function.
Finally, Wnt11 may also promote heart development by estab-
lishing proper left-right asymmetry. Core PCP genes in the mouse,
including Dvl and Vangl, are required for posterior positioning of
the nodal cilia to provide them with a posterior tilt (Hashimoto
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et al., 2010; Song et al., 2010). This posterior tilt allows rotational
movement of the cilia to generate a leftward ﬂuid in the node,
thereby initiating left-right axis establishment and proper heart
looping (Blum et al., 2009; Hirokawa et al., 2006). In Xenopus,
Wnt11 is expressed by cells in the superﬁcial mesoderm that
involute to form the gastrocoel roof plate (GRP), the left-right
organizer equivalent to the mouse node (Walentek et al., 2013).
BlockingWnt11 function in Xenopus perturbs GRP cilia polarization
and GRP morphogenesis (Walentek et al., 2013). Therefore, given
the strong and speciﬁc expression of Wnt11 in the mouse node
(Kispert et al., 1996) (Fig. 1, Suppl. Fig. S2), it may also play a role in
nodal cilia polarization to regulate left-right asymmetry and heart
looping in mammals.
In conclusion, our expression and lineage tracing studies with
Wnt11-CreER have revealed unexpected early and speciﬁc expres-
sion of Wnt11 in endodermal and endothelial progenitors during
mammalian gastrulation, and have outlined the highly dynamic
and ordered expression of Wnt11 in various cardiac lineages
during heart development. The insights gained from these ﬁndings
will guide future investigations to further decipher the role of non-
canonical Wnt/PCP signaling in gastrulation and cardiovascular
development.
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